Caspofungin
Deresinski, S. C., & Stevens, D. A. (2003). Caspofungin. CLINICAL INFECTIOUS DISEASES, 36(11), 1445–1457.

T-HELPER: automated support for community-based clinical research.
Musen, M. A., Carlson, R. W., Fagan, L. M., Deresinski, S. C., & Shortliffe, E. H. (1992). T-HELPER: automated support for community-based clinical research. Proceedings / the ... Annual Symposium on Computer Application [Sic] in Medical Care. Symposium on Computer Applications in Medical Care, 719–723.

Hyperimmune products in the prevention and therapy of infectious disease - A report of a hyperimmune products expert advisory panel
Deresinski, S. C. (2000). Hyperimmune products in the prevention and therapy of infectious disease - A report of a hyperimmune products expert advisory panel. BIODRUGS, 14(3), 147–158.

The efficacy and safety of ceftobiprole in the treatment of complicated skin and skin structure infections: evidence from 2 clinical trials
Deresinski, S. C. (2008). The efficacy and safety of ceftobiprole in the treatment of complicated skin and skin structure infections: evidence from 2 clinical trials. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 61(1), 103–9.

Ceftobiprole: breaking therapeutic dogmas of the beta-lactam class
Deresinski, S. C. (2008). Ceftobiprole: breaking therapeutic dogmas of the beta-lactam class. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 61(1), 82–85.

Expert Opinion: What To Do When There Is Coccidioides Exposure in a Laboratory
Stevens, D. A., Clemons, K. V., Levine, H. B., Pappagianis, D., Baron, E. J., Hamilton, J. R., … Johnson, N. (2009). Expert Opinion: What To Do When There Is Coccidioides Exposure in a Laboratory. CLINICAL INFECTIOUS DISEASES, 49(6), 919–923.

Ceftobiprole: a new cephalosporin for the treatment of skin and skin structure infections.
Schirmer, P. L., & Deresinski, S. C. (2009). Ceftobiprole: a new cephalosporin for the treatment of skin and skin structure infections. Expert Review of Anti-Infective Therapy, 7(7), 777–791.

INFLAMMATORY PSEUDOTUMOR OF INTRAABDOMINAL LYMPH-NODES MANIFESTING AS RECURRENT FEVER OF UNKNOWN ORIGIN - A CASE-REPORT
Kemper, C. A., Davis, R. E., Deresinski, S. C., & DORFMANN, R. F. (1991). INFLAMMATORY PSEUDOTUMOR OF INTRAABDOMINAL LYMPH-NODES MANIFESTING AS RECURRENT FEVER OF UNKNOWN ORIGIN - A CASE-REPORT. AMERICAN JOURNAL OF MEDICINE, 90(4), 519–23.

Immunotherapies for Staphylococcus aureus: Current Challenges and Future Prospects
Deresinski, S., & Herrera, V. (2010). Immunotherapies for Staphylococcus aureus: Current Challenges and Future Prospects. Presented at the 5th Decennial International Conference on Healthcare Associated Infections, ATLANTA,GA: UNIV CHICAGO PRESS.

VISCERAL BACILLARY EPITHELIOID ANGIOMATOSIS - POSSIBLE MANIFESTATIONS OF DISSEMINATED CAT SCRATCH DISEASE IN THE IMMUNOCOMPROMISED HOST - A REPORT OF 2 CASES
Kemper, C. A., Lombard, C. M., Deresinski, S. C., & Tompkins, L. S. (1990). VISCERAL BACILLARY EPITHELIOID ANGIOMATOSIS - POSSIBLE MANIFESTATIONS OF DISSEMINATED CAT SCRATCH DISEASE IN THE IMMUNOCOMPROMISED HOST - A REPORT OF 2 CASES. AMERICAN JOURNAL OF MEDICINE, 89(2), 216–222.

DISSEMINATED ACANTHAMOEBA INFECTION IN PATIENTS WITH AIDS - CASE-REPORTS AND REVIEW
SISON, J. P., Kemper, C. A., Loveless, M., McShane, D., Visvesvara, G. S., & Deresinski, S. C. (1995). DISSEMINATED ACANTHAMOEBA INFECTION IN PATIENTS WITH AIDS - CASE-REPORTS AND REVIEW. CLINICAL INFECTIOUS DISEASES, 20(5), 1207–1216.

HELICOBACTER-(CAMPYLOBACTER)-FENNELLIAE-LIKE ORGANISMS AS AN IMPORTANT BUT OCCULT CAUSE OF BACTEREMIA IN A PATIENT WITH AIDS
Kemper, C. A., MICKELSEN, P., Morton, A., Walton, B., & Deresinski, S. C. (1993). HELICOBACTER-(CAMPYLOBACTER)-FENNELLIAE-LIKE ORGANISMS AS AN IMPORTANT BUT OCCULT CAUSE OF BACTEREMIA IN A PATIENT WITH AIDS. JOURNAL OF INFECTION, 26(1), 97–101.

Frequency of Travel of Adults Infected with HIV.
Kemper, Linett, Kane, & Deresinski. (1995). Frequency of Travel of Adults Infected with HIV. Journal of Travel Medicine, 2(2), 85–88.

Upper and lower limb motor impairments in alcoholism, HIV infection, and their comorbidity
Fama, R., Eisen, J. C., Rosenbloom, M. J., Sassoon, S. A., Kemper, C. A., Deresinski, S., … Sullivan, E. V. (2007). Upper and lower limb motor impairments in alcoholism, HIV infection, and their comorbidity. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 31(6), 1038–1044.

Alcoholism, HIV infection, and their comorbidity: Factors affecting self-rated health-related quality of life
Rosenbloom, M. J., Sullivan, E. V., Sassoon, S. A., O'Reilly, A., Fama, R., Kemper, C. A., … Pfefferbaum, A. (2007). Alcoholism, HIV infection, and their comorbidity: Factors affecting self-rated health-related quality of life. JOURNAL OF STUDIES ON ALCOHOL AND DRUGS, 68(1), 115–125.

Mycobacterium avium complex infection in HIV infection
Kemper, C. A., & Deresinski, S. C. (1996). Mycobacterium avium complex infection in HIV infection. BAILLIERES CLINICAL INFECTIOUS DISEASES, 3(1), 103–122.

CELLULAR IMMUNITY TO COCCIDIOIDES-IMMITIS - INVITRO LYMPHOCYTE-RESPONSE TO SPHERULES, ARTHROSPORES, AND ENDOSPORES
Deresinski, S. C., Applegate, R. J., Levine, H. B., & Stevens, D. A. (1977). CELLULAR IMMUNITY TO COCCIDIOIDES-IMMITIS - INVITRO LYMPHOCYTE-RESPONSE TO SPHERULES, ARTHROSPORES, AND ENDOSPORES. CELLULAR IMMUNOLOGY, 32(1), 110–119.

SPHERULIN IN CLINICAL COCCIDIOIDOMYCOSIS - COMPARISON WITH COCCIDIOIDIN
Stevens, D. A., Levine, H. B., Deresinski, S. C., & BLAINE, L. J. (1975). SPHERULIN IN CLINICAL COCCIDIOIDOMYCOSIS - COMPARISON WITH COCCIDIOIDIN. CHEST, 68(5), 697–702.

FATAL GAS-GANGRENE FOLLOWING INTRA-ARTICULAR STEROID INJECTION
Yangco, B. G., Germain, B. F., & Deresinski, S. C. (1982). FATAL GAS-GANGRENE FOLLOWING INTRA-ARTICULAR STEROID INJECTION. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 283(2), 94–98.

THE INDIVIDUAL MICROBIOLOGIC EFFECT OF 3 ANTIMYCOBACTERIAL AGENTS, CLOFAZIMINE, ETHAMBUTOL, AND RIFAMPIN, ON MYCOBACTERIUM-AVIUM COMPLEX BACTEREMIA IN PATIENTS WITH AIDS
Kemper, C. A., Havlir, D., Haghighat, D., Dube, M., BARTOK, A. E., SISON, J. P., … Deresinski, S. C. (1994). THE INDIVIDUAL MICROBIOLOGIC EFFECT OF 3 ANTIMYCOBACTERIAL AGENTS, CLOFAZIMINE, ETHAMBUTOL, AND RIFAMPIN, ON MYCOBACTERIUM-AVIUM COMPLEX BACTEREMIA IN PATIENTS WITH AIDS. JOURNAL OF INFECTIOUS DISEASES, 170(1), 157–164.

DIAGNOSIS AND MANAGEMENT OF PNEUMONIA
Kemper, C. A., & Deresinski, S. C. (1991). DIAGNOSIS AND MANAGEMENT OF PNEUMONIA. PHARMACOTHERAPY, 11(2), S84–S89.

Posaconazole: A broad-spectrum triazole antifungal agent
Nagappan, V., & Deresinski, S. (2007). Posaconazole: A broad-spectrum triazole antifungal agent. CLINICAL INFECTIOUS DISEASES, 45(12), 1610–1617.

The potential role of GM-CSF and G-CSF in infectious diseases
Deresinski, S. C., & Kemper, C. A. (1998). The potential role of GM-CSF and G-CSF in infectious diseases. INFECTIONS IN MEDICINE, 15(12), 856-?

CD20 EXPRESSION IS INCREASED ON LYMPHOCYTES-B FROM HIV-INFECTED INDIVIDUALS
Staal, F. J. T., Roederer, M., BUBP, J., Mole, L. A., Anderson, M. T., Raju, P. A., … Herzenberg, L. A. (1992). CD20 EXPRESSION IS INCREASED ON LYMPHOCYTES-B FROM HIV-INFECTED INDIVIDUALS. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 5(6), 627–632.

Dysfunctional monocytes from a patient with disseminated Mycobacterium kansasii infection are activated in vitro and in vivo by GM-CSF
Bermudez, L. E., Kemper, C. A., & Deresinski, S. C. (1995). Dysfunctional monocytes from a patient with disseminated Mycobacterium kansasii infection are activated in vitro and in vivo by GM-CSF. BIOTHERAPY, 8(2), 135–142.

ASSOCIATION OF ABO BLOOD-GROUP AND OUTCOME OF COCCIDIOIDAL INFECTION
Deresinski, S. C., Pappagianis, D., & Stevens, D. A. (1979). ASSOCIATION OF ABO BLOOD-GROUP AND OUTCOME OF COCCIDIOIDAL INFECTION. SABOURAUDIA-JOURNAL OF MEDICAL AND VETERINARY MYCOLOGY, 17(3), 261–264.

A STEPWISE GUIDE FOR TREATING TUBERCULOSIS
Deresinski, S. C. (1984). A STEPWISE GUIDE FOR TREATING TUBERCULOSIS. WESTERN JOURNAL OF MEDICINE, 141(4), 546–548.

Methicillin-Resistant Staphylococcus aureus and Vancomycin: Minimum Inhibitory Concentration Matters
Deresinski, S. (2012). Methicillin-Resistant Staphylococcus aureus and Vancomycin: Minimum Inhibitory Concentration Matters. CLINICAL INFECTIOUS DISEASES, 54(6), 772–774.

Vancomycin Heteroresistance and Methicillin-Resistant Staphylococcus aureus
Deresinski, S. (2009). Vancomycin Heteroresistance and Methicillin-Resistant Staphylococcus aureus. JOURNAL OF INFECTIOUS DISEASES, 199(5), 605–609.

CUTANEOUS TUBERCULOSIS
CHAMPSI, J. H., & Deresinski, S. (1992). CUTANEOUS TUBERCULOSIS. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 268(10), 1339–1339.

Guiding Clinical Care through Evidence-Free Zones
Deresinski, S. (2010). Guiding Clinical Care through Evidence-Free Zones. CLINICAL INFECTIOUS DISEASES, 51(10), 1157–1159.

SPHERULIN IN CLINICAL COCCIDIOIDOMYCOSIS - COMPARISON WITH COCCIDIOIDIN
Stevens, D. A., Levine, H. B., Deresinski, S. C., & BLAINE, L. J. (1976). SPHERULIN IN CLINICAL COCCIDIOIDOMYCOSIS - COMPARISON WITH COCCIDIOIDIN. BOLETIN DE LA OFICINA SANITARIA PANAMERICANA, 80(4), 333–341.

CLINICAL EVALUATION OF PARENTERAL DICLOXACILLIN
Deresinski, S. C., & Stevens, D. A. (1975). CLINICAL EVALUATION OF PARENTERAL DICLOXACILLIN. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 18(1), 151–162.

BONE AND JOINT COCCIDIOIDOMYCOSIS TREATED WITH MICONAZOLE
Deresinski, S. C., & Stevens, D. A. (1979). BONE AND JOINT COCCIDIOIDOMYCOSIS TREATED WITH MICONAZOLE. AMERICAN REVIEW OF RESPIRATORY DISEASE, 120(5), 1101–1107.

Azithromycin prophylaxis during a hospitalwide outbreak of a pertussis-like illness
Martinez, S. M., Kemper, C. A., Haiduven, D., Cody, S. H., & Deresinski, S. C. (2001). Azithromycin prophylaxis during a hospitalwide outbreak of a pertussis-like illness. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 22(12), 781–783.

The prevalence of measles antibody in human immunodeficiency virus-infected patients in northern California
Kemper, C. A., Gangar, M., ARIAS, G., Kane, C., & Deresinski, S. C. (1998). The prevalence of measles antibody in human immunodeficiency virus-infected patients in northern California. JOURNAL OF INFECTIOUS DISEASES, 178(4), 1177–1180.

MICONAZOLE IN COCCIDIOIDOMYCOSIS .2. THERAPEUTIC AND PHARMACOLOGIC STUDIES IN MAN
Stevens, D. A., Levine, H. B., & Deresinski, S. C. (1976). MICONAZOLE IN COCCIDIOIDOMYCOSIS .2. THERAPEUTIC AND PHARMACOLOGIC STUDIES IN MAN. AMERICAN JOURNAL OF MEDICINE, 60(2), 191–202.

TREATMENT OF FUNGAL MENINGITIS WITH MICONAZOLE
Deresinski, S. C., Lilly, R. B., Levine, H. B., Galgiani, J. N., & Stevens, D. A. (1977). TREATMENT OF FUNGAL MENINGITIS WITH MICONAZOLE. ARCHIVES OF INTERNAL MEDICINE, 137(9), 1180–1185.

Vancomycin: does it still have a role as an antistaphylococcal agent?
Deresinski, S. (2007). Vancomycin: does it still have a role as an antistaphylococcal agent? EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 5(3), 393–401.

Principles of antibiotic therapy in severe infections: Optimizing the therapeutic approach by use of laboratory and clinical data
Deresinski, S. (2007). Principles of antibiotic therapy in severe infections: Optimizing the therapeutic approach by use of laboratory and clinical data. CLINICAL INFECTIOUS DISEASES, 45, S177–S183.

COCCIDIOIDES IMMITIS ENDOSPORES - PHAGOCYTOSIS BY HUMAN CELLS
Deresinski, S. C., Levine, H. B., & Stevens, D. A. (1978). COCCIDIOIDES IMMITIS ENDOSPORES - PHAGOCYTOSIS BY HUMAN CELLS. MYCOPATHOLOGIA, 64(3), 179–181.

Safety and immunogenicity of hepatitis A vaccine in human immunodeficiency virus-infected patients: A double-blind, randomized, placebo-controlled trial
Kemper, C. A., Haubrich, R., Frank, I., Dubin, G., Buscarino, C., McCutchan, J. A., & Deresinski, S. C. (2003). Safety and immunogenicity of hepatitis A vaccine in human immunodeficiency virus-infected patients: A double-blind, randomized, placebo-controlled trial. JOURNAL OF INFECTIOUS DISEASES, 187(8), 1327–1331.

PSEUDOMONAS-MALTOPHILIA CAUSING HEROIN-ASSOCIATED INFECTIVE ENDOCARDITIS
Yu, V. L., RUMANS, L. W., Wing, E. J., McLeod, R., SATTLER, F. N., Harvey, R. M., & Deresinski, S. C. (1978). PSEUDOMONAS-MALTOPHILIA CAUSING HEROIN-ASSOCIATED INFECTIVE ENDOCARDITIS. ARCHIVES OF INTERNAL MEDICINE, 138(11), 1667–1671.

Antibiotic therapy of vascular catheter-related bloodstream infections: is vancomycin the optimal choice for Staphylococcus aureus infections?
Deresinski, S. (2009). Antibiotic therapy of vascular catheter-related bloodstream infections: is vancomycin the optimal choice for Staphylococcus aureus infections? International Journal of Antimicrobial Agents, 34, S43–6.

Evolution of the clinical manifestations of infection during the course of febrile neutropenia in patients with malignancy
Dompeling, E. C., Donnelly, J. P., Raemaekers, J. M. M., Deresinski, S. C., Feld, R., & De Pauw, B. E. (1998). Evolution of the clinical manifestations of infection during the course of febrile neutropenia in patients with malignancy. INFECTION, 26(6), 349–354.

COCCIDIOIDOMYCOSIS IN COMPROMISED HOSTS - EXPERIENCE AT STANFORD-UNIVERSITY-HOSPITAL
Deresinski, S. C., & Stevens, D. A. (1975). COCCIDIOIDOMYCOSIS IN COMPROMISED HOSTS - EXPERIENCE AT STANFORD-UNIVERSITY-HOSPITAL. MEDICINE, 54(5), 377–395.

NORFLOXACIN FOR PREVENTION OF BACTERIAL-INFECTIONS IN GRANULOCYTOPENIC PATIENTS
Winston, D. J., Ho, W. G., Champlin, R. E., Karp, J., Bartlett, J., Finley, R. S., … Corrado, M. (1987). NORFLOXACIN FOR PREVENTION OF BACTERIAL-INFECTIONS IN GRANULOCYTOPENIC PATIENTS. AMERICAN JOURNAL OF MEDICINE, 82(6B), 40–46.

ULCERATIVE AND PLAQUE-LIKE TRACHEOBRONCHITIS DUE TO INFECTION WITH ASPERGILLUS IN PATIENTS WITH AIDS
Kemper, C. A., HOSTETLER, J. S., Follansbee, S. E., Ruane, P., Covington, D., Leong, S. S., … Stevens, D. A. (1993). ULCERATIVE AND PLAQUE-LIKE TRACHEOBRONCHITIS DUE TO INFECTION WITH ASPERGILLUS IN PATIENTS WITH AIDS. CLINICAL INFECTIOUS DISEASES, 17(3), 344–52.

Counterpoint: Vancomycin and Staphylococcus aureus - An antibiotic enters obsolescence
Deresinski, S. (2007). Counterpoint: Vancomycin and Staphylococcus aureus - An antibiotic enters obsolescence. CLINICAL INFECTIOUS DISEASES, 44(12), 1543–1548.

Immunomodulatory treatment of Mycobacterium avium complex bacteremia in patients with AIDS by use of recombinant granulocyte-macrophage colony-stimulating factor
Kemper, C. A., Bermudez, L. E., & Deresinski, S. C. (1998). Immunomodulatory treatment of Mycobacterium avium complex bacteremia in patients with AIDS by use of recombinant granulocyte-macrophage colony-stimulating factor. JOURNAL OF INFECTIOUS DISEASES, 177(4), 914–920.

CEFTAZIDIME COMPARED WITH PIPERACILLIN AND TOBRAMYCIN FOR THE EMPIRIC TREATMENT OF FEVER IN NEUTROPENIC PATIENTS WITH CANCER - A MULTICENTER RANDOMIZED TRIAL
dePauw, B. E., Deresinski, S. C., Feld, R., LANEALLMAN, E. F., & Donnelly, J. P. (1994). CEFTAZIDIME COMPARED WITH PIPERACILLIN AND TOBRAMYCIN FOR THE EMPIRIC TREATMENT OF FEVER IN NEUTROPENIC PATIENTS WITH CANCER - A MULTICENTER RANDOMIZED TRIAL. ANNALS OF INTERNAL MEDICINE, 120(10), 834–844.

Vancomycin in Combination with Other Antibiotics for the Treatment of Serious Methicillin-Resistant Staphylococcus aureus Infections
Deresinski, S. (2009). Vancomycin in Combination with Other Antibiotics for the Treatment of Serious Methicillin-Resistant Staphylococcus aureus Infections. CLINICAL INFECTIOUS DISEASES, 49(7), 1072–1079.

The Multiple Paths to Heteroresistance and Intermediate Resistance to Vancomycin in Staphylococcus aureus.
Deresinski, S. (2013). The Multiple Paths to Heteroresistance and Intermediate Resistance to Vancomycin in Staphylococcus aureus. Journal of Infectious Diseases, 208(1), 7–9.

Antistaphylococcal vaccines and immunloglobulins - Current status and future prospects
Deresinski, S. (2006). Antistaphylococcal vaccines and immunloglobulins - Current status and future prospects. DRUGS, 66(14), 1797–1806.

Phase III study of granulocyte-macrophage colony-stimulating factor in advanced HIV disease: effect on infections, CD4 cell counts and HIV suppression
Angel, J. B., High, K., Rhame, F., Brand, D., Whitmore, J. B., Agosti, J. M., … Deresinski, S. (2000). Phase III study of granulocyte-macrophage colony-stimulating factor in advanced HIV disease: effect on infections, CD4 cell counts and HIV suppression. AIDS, 14(4), 387–395.

DISSEMINATED HERPES-SIMPLEX IN UNTREATED MULTIPLE-MYELOMA - PARADOX OF PRESENT CONCEPTS OF IMMUNE DEFECTS
Deresinski, S. C., & Stevens, D. A. (1974). DISSEMINATED HERPES-SIMPLEX IN UNTREATED MULTIPLE-MYELOMA - PARADOX OF PRESENT CONCEPTS OF IMMUNE DEFECTS. ONCOLOGY, 30(4), 318–323.

Bacteriophage Therapy: Exploiting Smaller Fleas
Deresinski, S. (2009). Bacteriophage Therapy: Exploiting Smaller Fleas. CLINICAL INFECTIOUS DISEASES, 48(8), 1096–1101.

Granulocyte-macrophage colony-stimulating factor: potential therapeutic, immunological and antiretroviral effects in HIV infection
Deresinski, S. C. (1999). Granulocyte-macrophage colony-stimulating factor: potential therapeutic, immunological and antiretroviral effects in HIV infection. AIDS, 13(6), 633–643.

Early identification of neutropenic patients at risk of grampositive bacteraemia and the impact of empirical administration of vancomycin
Dompeling, E. C., Donnelly, J. P., Deresinski, S. C., Feld, R., LANEALLMAN, E. F., & dePauw, B. E. (1996). Early identification of neutropenic patients at risk of grampositive bacteraemia and the impact of empirical administration of vancomycin. EUROPEAN JOURNAL OF CANCER, 32A(8), 1332–1339.

Methicillin-resistant Staphylococcus aureus: An evolutionary, epidemiologic, and therapeutic odyssey
Deresinski, S. (2005). Methicillin-resistant Staphylococcus aureus: An evolutionary, epidemiologic, and therapeutic odyssey. CLINICAL INFECTIOUS DISEASES, 40(4), 562–573.

DEVELOPMENT OF ASPERGILLUS SINUSITIS IN A PATIENT RECEIVING AMPHOTERICIN-B - TREATMENT WITH GRANULOCYTE TRANSFUSIONS
Swerdlow, B., & Deresinski, S. (1984). DEVELOPMENT OF ASPERGILLUS SINUSITIS IN A PATIENT RECEIVING AMPHOTERICIN-B - TREATMENT WITH GRANULOCYTE TRANSFUSIONS. AMERICAN JOURNAL OF MEDICINE, 76(1), 162–166.

Tenofovir disoproxil fumarate
Gallant, J. E., & Deresinski, S. (2003). Tenofovir disoproxil fumarate. CLINICAL INFECTIOUS DISEASES, 37(7), 944–950.

THE HAMSTER MODEL OF CHRONIC MYCOBACTERIUM-AVIUM COMPLEX INFECTION
Yangco, B. G., LACKMANSMITH, C., Espinoza, C. G., Solomon, D. A., & Deresinski, S. C. (1989). THE HAMSTER MODEL OF CHRONIC MYCOBACTERIUM-AVIUM COMPLEX INFECTION. JOURNAL OF INFECTIOUS DISEASES, 159(3), 556–561.

Rare and emerging viral infections in transplant recipients.
Waggoner, J. J., Soda, E. A., & Deresinski, S. (2013). Rare and emerging viral infections in transplant recipients. Clinical Infectious Diseases , 57(8), 1182–1188.

SOLUBLE-ANTIGENS OF MYCELIA AND SPHERULES IN INVITRO DETECTION OF IMMUNITY TO COCCIDIOIDES-IMMITIS
DERESINS, S. C., Levine, H. B., & Stevens, D. A. (1974). SOLUBLE-ANTIGENS OF MYCELIA AND SPHERULES IN INVITRO DETECTION OF IMMUNITY TO COCCIDIOIDES-IMMITIS. INFECTION AND IMMUNITY, 10(4), 700–704.

Utility of DNA Sequencing for Direct Identification of Invasive Fungi From Fresh and Formalin-Fixed Specimens
Moncada, P. A., Budvytiene, I., Ho, D. Y., Deresinski, S. C., Montoya, J. G., & Banaei, N. (2013). Utility of DNA Sequencing for Direct Identification of Invasive Fungi From Fresh and Formalin-Fixed Specimens. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 140(2), 203–8.

T-HELPER - AUTOMATED SUPPORT FOR COMMUNITY-BASED CLINICAL RESEARCH
Musen, M. A., Carlson, R. W., Fagan, L. M., Deresinski, S. C., & Shortliffe, E. H. (1993). T-HELPER - AUTOMATED SUPPORT FOR COMMUNITY-BASED CLINICAL RESEARCH. Presented at the 16th Annual Symposium on Computer Applications in Medical Care, BALTIMORE,MD: MCGRAW-HILL BOOK CO.

Treatment of Mycobacterium avium complex infection: Do the results of in vitro susceptibility tests predict therapeutic outcome in humans?
SISON, J. P., Yao, Y. Z., Kemper, C. A., Hamilton, J. R., Brummer, E., Stevens, D. A., & Deresinski, S. C. (1996). Treatment of Mycobacterium avium complex infection: Do the results of in vitro susceptibility tests predict therapeutic outcome in humans? JOURNAL OF INFECTIOUS DISEASES, 173(3), 677–683.

Treatment of Mycobacterium avium complex infection: Does the beige mouse model predict therapeutic outcome in humans?
SISON, J. P., Yao, Y. Z., Kemper, C. A., Hamilton, J. R., DRUMMER, E., Stevens, D. A., & Deresinski, S. C. (1996). Treatment of Mycobacterium avium complex infection: Does the beige mouse model predict therapeutic outcome in humans? JOURNAL OF INFECTIOUS DISEASES, 173(3), 750–753.

Aspergillus fumigatus infection of an automatic internal cardiac defibrillator
Dunn, C. J., Ruder, M., & Deresinski, S. C. (1996). Aspergillus fumigatus infection of an automatic internal cardiac defibrillator. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 19(12), 2156–2157.

Histoplasma capsulatum Endocarditis: Multicenter Case Series with Review of Current Diagnostic Techniques and Treatment.
Riddell, J., Kauffman, C. A., Smith, J. A., Assi, M., Blue, S., Buitrago, M. I., … Wheat, L. J. (2014). Histoplasma capsulatum Endocarditis: Multicenter Case Series with Review of Current Diagnostic Techniques and Treatment. Medicine, 93(5), 186–193.

Carbapenemase-producing Klebsiella pneumoniae.
Robilotti, E., & Deresinski, S. (2014). Carbapenemase-producing Klebsiella pneumoniae. F1000prime Reports, 6, 80-?

Norovirus.
Robilotti, E., Deresinski, S., & Pinsky, B. A. (2015). Norovirus. Clinical Microbiology Reviews, 28(1), 134–64.

NECROTIZING OR CAVITATING PNEUMONIA DUE TO STREPTOCOCCUS-PNEUMONIAE - REPORT OF 4 CASES AND REVIEW OF THE LITERATURE
Yangco, B. G., & Deresinski, S. C. (1980). NECROTIZING OR CAVITATING PNEUMONIA DUE TO STREPTOCOCCUS-PNEUMONIAE - REPORT OF 4 CASES AND REVIEW OF THE LITERATURE. MEDICINE, 59(6), 449–457.

Case report. Fatal gas gangrene following intra-articular steroid injection.
Yangco, B. G., Germain, B. F., & Deresinski, S. C. (1982). Case report. Fatal gas gangrene following intra-articular steroid injection. The American Journal of the Medical Sciences, 283(2), 94–98.

ORAL ATOVAQUONE COMPARED WITH INTRAVENOUS PENTAMIDINE FOR PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS WITH AIDS
Dohn, M. N., Weinberg, W. G., Torres, R. A., Follansbee, S. E., Caldwell, P. T., Scott, J. D., … Rogers, M. (1994). ORAL ATOVAQUONE COMPARED WITH INTRAVENOUS PENTAMIDINE FOR PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS WITH AIDS. ANNALS OF INTERNAL MEDICINE, 121(3), 174–180.

EFFICACY OF RIFABUTIN IN THE TREATMENT OF DISSEMINATED INFECTION DUE TO MYCOBACTERIUM-AVIUM COMPLEX
Sullam, P. M., Gordin, F. M., Wynne, B. A., Smith, J., Schoenfelder, J., Nakata, M., … ZIDE, N. (1994). EFFICACY OF RIFABUTIN IN THE TREATMENT OF DISSEMINATED INFECTION DUE TO MYCOBACTERIUM-AVIUM COMPLEX. CLINICAL INFECTIOUS DISEASES, 19(1), 84–86.

TREATMENT OF MYCOBACTERIUM-AVIUM COMPLEX BACTEREMIA IN AIDS WITH A 4-DRUG ORAL REGIMEN - RIFAMPIN, ETHAMBUTOL, CLOFAZIMINE, AND CIPROFLOXACIN
Kemper, C. A., Meng, T. C., Nussbaum, J., Chiu, J., FEIGAL, D. F., BARTOK, A. E., … McCutchan, J. A. (1992). TREATMENT OF MYCOBACTERIUM-AVIUM COMPLEX BACTEREMIA IN AIDS WITH A 4-DRUG ORAL REGIMEN - RIFAMPIN, ETHAMBUTOL, CLOFAZIMINE, AND CIPROFLOXACIN. ANNALS OF INTERNAL MEDICINE, 116(6), 466–472.

RAPID RADIOMETRIC METHOD FOR DETERMINING DRUG SUSCEPTIBILITY OF MYCOBACTERIUM-AVIUM-INTRACELLULARE
Yangco, B. G., Eikman, E. A., Solomon, D. A., Deresinski, S. C., & Madden, J. A. (1981). RAPID RADIOMETRIC METHOD FOR DETERMINING DRUG SUSCEPTIBILITY OF MYCOBACTERIUM-AVIUM-INTRACELLULARE. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 19(4), 534–539.

Mycobacterium avium complex infection in AIDS.
Kemper, C. A., & Deresinski, S. C. (1995). Mycobacterium avium complex infection in AIDS. AIDS Clinical Review, 153–228.

Travels with HIV: The compliance and health of HIV-infected adults who travel
Kemper, C. A., Linett, A., Kane, C., & Deresinski, S. C. (1997). Travels with HIV: The compliance and health of HIV-infected adults who travel. INTERNATIONAL JOURNAL OF STD & AIDS, 8(1), 44–49.

Dysfunctional monocytes from a patient with disseminated Mycobacterium kansasii infection are activated in vitro and in vivo by GM-CSF.
Bermudez, L. E., Kemper, C. A., & Deresinski, S. C. (1994). Dysfunctional monocytes from a patient with disseminated Mycobacterium kansasii infection are activated in vitro and in vivo by GM-CSF. Biotherapy , 8(2), 135–142.

FLUBENDAZOLE AND MEBENDAZOLE IN THE TREATMENT OF TRICHURIASIS AND OTHER HELMINTHIASES
Yangco, B. G., Klein, T. W., Deresinski, S. C., Vickery, A. C., & Craig, C. P. (1981). FLUBENDAZOLE AND MEBENDAZOLE IN THE TREATMENT OF TRICHURIASIS AND OTHER HELMINTHIASES. CLINICAL THERAPEUTICS, 4(4), 285–290.

First case of infectious endocarditis caused by Parvimonas micra.
Gomez, C. A., Gerber, D. A., Zambrano, E., Banaei, N., Deresinski, S., & Blackburn, B. G. (2015). First case of infectious endocarditis caused by Parvimonas micra. Anaerobe, 36, 53–55.

Oral atovaquone compared with intravenous pentamidine for Pneumocystis carinii pneumonia in patients with AIDS. Atovaquone Study Group.
Dohn, M. N., Weinberg, W. G., Torres, R. A., Follansbee, S. E., Caldwell, P. T., Scott, J. D., … Lancaster, D. J. (1994). Oral atovaquone compared with intravenous pentamidine for Pneumocystis carinii pneumonia in patients with AIDS. Atovaquone Study Group. Annals of Internal Medicine, 121(3), 174–180.

Bacteremia due to Methicillin-Resistant Staphylococcus aureus New Therapeutic Approaches
Holubar, M., Meng, L., & Deresinski, S. (2016). Bacteremia due to Methicillin-Resistant Staphylococcus aureus New Therapeutic Approaches. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 30(2), 491-?

Outpatient hydroxychloroquine prescribing at a large academic health system during the COVID-19 pandemic.
Ha, D. R., Kuo, J., Aung, P. S., Chang, T., Witt, L. G., Alegria, W., … Deresinski, S. P. (2020). Outpatient hydroxychloroquine prescribing at a large academic health system during the COVID-19 pandemic. Infection Control and Hospital Epidemiology, 1–8.

Impact of Rapid Antimicrobial Susceptibility Testing in Gram-negative Rod Bacteremia: A Quasi-Experimental Study.
Hogan, C. A., Ebunji, B., Watz, N., Kapphahn, K., Rigdon, J., Mui, E., … Banaei, N. (2020). Impact of Rapid Antimicrobial Susceptibility Testing in Gram-negative Rod Bacteremia: A Quasi-Experimental Study. Journal of Clinical Microbiology.

Significance of bacterial and viral genotypes as a risk factor in driving cancer (Review).
Jangam, D., Butzmann, A., Sridhar, K., Deresinski, S., Banaei, N., & Shigeo Ohgami, R. (2020). Significance of bacterial and viral genotypes as a risk factor in driving cancer (Review). Molecular and Clinical Oncology, 13(1), 3–12.

Cost-effectiveness of bezlotoxumab and fidaxomicin for initial Clostridioides difficile infection.
Chen, J., Gong, C. L., Hitchcock, M. M., Holubar, M., Deresinski, S., & Hay, J. W. (2021). Cost-effectiveness of bezlotoxumab and fidaxomicin for initial Clostridioides difficile infection. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases.

Sustained Reduction in Urgent Care Antibiotic Prescribing During the Coronavirus Disease 2019 Pandemic: An Academic Medical Center's Experience.
Ha, D., Ong'uti, S., Chang, A., Mui, E., Nelligan, I., Betts, B., … Holubar, M. (1800). Sustained Reduction in Urgent Care Antibiotic Prescribing During the Coronavirus Disease 2019 Pandemic: An Academic Medical Center's Experience. Open Forum Infectious Diseases, 9(2), ofab662.

Coccidioides Species: A Review of Basic Research: 2022.
Kirkland, T. N., Stevens, D. A., Hung, C.-Y. Y., Beyhan, S., Taylor, J. W., Shubitz, L. F., … Fierer, J. (2022). Coccidioides Species: A Review of Basic Research: 2022. Journal of Fungi (Basel, Switzerland), 8(8).

Risk factors and outcomes associated with persistent vancomycin resistant Enterococcal Bacteremia.
Fox, E., Ha, D., Bounthavong, M., Meng, L., Mui, E., Holubar, M., … Alegria, W. (2022). Risk factors and outcomes associated with persistent vancomycin resistant Enterococcal Bacteremia. BMC Infectious Diseases, 22(1), 855.

Utility of DNA Sequencing for Direct Identification of Invasive Fungi From Fresh and Formalin-Fixed Specimens
Moncada, P. A., Budvytiene, I., Ho, D. Y., Deresinski, S. C., Montoya, J. G., & Banaei, N. (2013). Utility of DNA Sequencing for Direct Identification of Invasive Fungi From Fresh and Formalin-Fixed Specimens. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 140(2), 203–208.

Piperacillin/tazobactam versus cefepime or carbapenems for cefoxitin-non-susceptible Enterobacter cloacae, Klebsiella aerogenes, Citrobacter freundii, Serratia marcescens and Morganella morganii bacteraemia in immunocompromised patients.
Lu, B., Wong, M., Ha, D., Bounthavong, M., Banaei, N., Deresinski, S., & Diep, C. (2023). Piperacillin/tazobactam versus cefepime or carbapenems for cefoxitin-non-susceptible Enterobacter cloacae, Klebsiella aerogenes, Citrobacter freundii, Serratia marcescens and Morganella morganii bacteraemia in immunocompromised patients. The Journal of Antimicrobial Chemotherapy.

Anticytokine Autoantibodies and Fungal Infections.
Kappagoda, S., & Deresinski, S. (2023). Anticytokine Autoantibodies and Fungal Infections. Journal of Fungi (Basel, Switzerland), 9(8).